Barak Özer Ayşegül, Eröz Pınar
Psychiatry, Niğde Ömer Halisdemir University Training and Research Hospital, Niğde, TUR.
Ophthalmology, Tarsus State Hospital, Mersin, TUR.
Cureus. 2024 Jul 9;16(7):e64162. doi: 10.7759/cureus.64162. eCollection 2024 Jul.
Introduction Glaucoma is a chronic disease that can lead to severe visual impairment and blindness. Methods The study included 91 primary open-angle glaucoma patients aged 60 years and older (group 1) and 83 healthy controls (group 2) with similar age and gender distribution. The duration of the disease, the number of anti-glaucomatous drops used daily, and visual field parameters were recorded. All participants then underwent a comprehensive mental status examination by a psychiatrist and were administered the Geriatric Depression Scale (GDS). Results In Group 1, the mean duration of glaucoma was 10.2±6.0 years, and the mean number of drops used per day was 2.91±1.47 drops/day. According to visual field (24-2) data, the mean mean deviation (MD) was -7.76±4.78 dB and the mean pattern standard deviation (PSD) was 5.14±2.60 dB. According to the classification based on MD, 33 (36.3%) patients were in the early stage, 36 (39.5%) in the intermediate stage, and 22 (24.2%) in the advanced stage. The mean best-corrected visual acuity (BCVA) was 0.85±0.38 logMAR in group 1 and 0.34±0.19 logMAR in group 2. The mean GDS scores were 13.7±7.23 points in group 1 and 3.61±1.71 points in group 2. There were statistically significant differences between the groups in terms of BCVA and GDS scores (p=0.039 and p<0.001, respectively). Conclusion In conclusion, it is important that ophthalmologists provide adequate information about glaucoma to prevent the development of depression in patients with glaucoma. This information may protect patients from uncertainty. A multidisciplinary approach in the management of glaucoma, a chronic and vision-threatening disease, can positively affect patients' compliance with follow-up and treatment, increase the quality of healthcare, and improve treatment responses.
引言 青光眼是一种可导致严重视力损害和失明的慢性疾病。方法 该研究纳入了91例60岁及以上的原发性开角型青光眼患者（第1组）和83例年龄和性别分布相似的健康对照者（第2组）。记录疾病持续时间、每日使用的抗青光眼滴眼液数量和视野参数。然后，所有参与者均由精神科医生进行全面的精神状态检查，并接受老年抑郁量表（GDS）测试。结果 在第1组中，青光眼的平均病程为10.2±6.0年，每日平均滴眼液使用量为2.91±1.47滴/天。根据视野（24-2）数据，平均平均偏差（MD）为-7.76±4.78 dB，平均模式标准偏差（PSD）为5.14±2.60 dB。根据基于MD的分类，33例（36.3%）患者处于早期，36例（39.5%）处于中期，22例（24.2%）处于晚期。第1组的平均最佳矫正视力（BCVA）为0.85±0.38 logMAR，第2组为0.34±0.19 logMAR。第1组的平均GDS评分为13.7±7.23分，第2组为3.61±1.71分。两组在BCVA和GDS评分方面存在统计学显著差异（分别为p=0.039和p<0.001）。结论 总之，眼科医生提供有关青光眼的充分信息对于预防青光眼患者发生抑郁很重要。这些信息可能使患者免受不确定性的影响。对于青光眼这种慢性且威胁视力的疾病，采用多学科方法进行管理可对患者的随访和治疗依从性产生积极影响，提高医疗质量，并改善治疗反应。
